Quality of life improvement in a patient with severe atopic dermatitis treated with photopheresis

被引：31
|
作者：
Mohla, G [1 ]
Horvath, N [1 ]
Stevens, S [1 ]
机构：
[1] Case Western Reserve Univ, Univ Hosp Cleveland, Ireland Canc Ctr, Photopheresis Serv, Cleveland, OH USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 1999年 / 40卷 / 05期
关键词：
D O I：
10.1016/S0190-9622(99)70167-2
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Atopic dermatitis is a common skin disease characterized by severely pruritic eczematous patches, papular and lichenified plaques, excoriations, cracks, and erosions. Photopheresis has been shown to ameliorate the signs and symptoms of atopic dermatitis in some patients. We describe successful results with photopheresis for refractory disease in a patient who chronicled his quality of life weekly for more than 15 years before and during extracorporeal photochemotherapy.
引用
收藏
页码：780 / 782
页数：3
相关论文
共 50 条
  • [21] Improvement of alopecia areata with Dupilumab in a patient with severe atopic dermatitis and review the literature
    Magdaleno-Tapial, Jorge
    Valenzuela-Onate, Cristian
    Garcia-Legaz-Martinez, Marta
    Martinez-Domenech, Alvaro
    Perez-Ferriols, Amparo
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2020, 61 (02) : E223 - E225
  • [22] Lifelong Impact of Severe Atopic Dermatitis on Quality of Life: A Case Report
    Bashyam, Arjun M.
    Ganguli, Sohini
    Mahajan, Puneet
    Feldman, Steven R.
    DERMATOLOGY AND THERAPY, 2021, 11 (03) : 1065 - 1070
  • [23] Targeted Combined Endpoint Improvement in Patient and Disease Domains in Atopic Dermatitis: A Treat-to-Target Analysis of Adults with Moderate-to-Severe Atopic Dermatitis Treated with Upadacitinib
    Kwatra, Shawn G.
    De Bruin-Weller, Marjolein
    Silverberg, Jonathan I.
    Lio, Peter
    Deleuran, Mette
    Aydin, Handan
    Calimlim, Brian M.
    Lane, Michael C.
    Liu, Yingyi
    Ofori, Sarah
    Weidinger, Stephan
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [24] Severe atopic dermatitis in a patient with Loeys--Dietz syndrome treated with dupilumab
    Gkalpakiotis, Spyridon
    Maresova, Tereza
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (01) : E70 - E72
  • [25] Patient-reported outcomes and quality of life measures in atopic dermatitis
    Vakharia, Paras P.
    Cella, David
    Silverberg, Jonathan, I
    CLINICS IN DERMATOLOGY, 2018, 36 (05) : 616 - 630
  • [26] Dupilumab therapy in a patient with atopic dermatitis and severe atopic keratoconjunctivitis
    Gkalpakiotis, S.
    Arenberger, P.
    Skalicka, P.
    Arenbergerova, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (06) : E281 - E283
  • [27] Crisaborole demonstrates improvement in quality of life in patients with mild to moderate atopic dermatitis
    Simpson, E.
    Paller, A.
    Boguniewicz, M.
    Eichenfield, L.
    Feldman, S.
    Silverberg, J.
    Chamlin, S.
    Zane, L.
    EXPERIMENTAL DERMATOLOGY, 2016, 25 : 28 - 29
  • [28] The Impact of Atopic Dermatitis on Quality of Life
    Lifschitz, Carlos
    ANNALS OF NUTRITION AND METABOLISM, 2015, 66 : 34 - 40
  • [29] Quality of Life in Patients With Atopic Dermatitis
    Koszoru, Kamilla
    Borza, Julia
    Gulacsi, Laszlo
    Sardy, Miklos
    CUTIS, 2019, 104 (03): : 174 - 177
  • [30] CRISABOROLE DEMONSTRATES IMPROVEMENT IN QUALITY OF LIFE IN PATIENTS WITH MILD TO MODERATE ATOPIC DERMATITIS
    Simpson, E.
    Paller, A.
    Boguniewicz, M.
    Eichenfield, L.
    Feldman, S.
    Silverberg, J.
    Chamlin, S.
    Zane, L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S20 - S21
12345